Antiviral Drugs Market Size, Share & Trends Report

Antiviral Drugs Market Size, Share & Trends Analysis Report By Type (Branded, Generics), By Drug Class, By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-389-8
  • Number of Report Pages: 180
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2021
  • Forecast Period: 2023 - 2030
  • Industry: Healthcare

Market Segmentation

  • Antiviral Drugs Type Scope Outlook (Revenue, USD Million, 2018 - 2030)
    • Branded
    • Generics
  • Antiviral Drug Class Scope Outlook (Revenue, USD Million, 2018 - 2030)
    • DNA Polymerase Inhibitors
    • Reverse Transcriptase Inhibitors
    • Protease Inhibitors
    • Neuraminidase Inhibitors
    • Others
  • Antiviral Drugs Distribution Channel Scope Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Antiviral Drugs Application Scope Outlook (Revenue, USD Million, 2018 - 2030)
    • HIV
    • Hepatitis
    • Herpes
    • Influenza
    • Others
  • Antiviral Drugs Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
        • Branded
        • Generics
      • North America Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • North America Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • North America Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • U.S.
        • U.S. Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • U.S. Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • U.S. Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • U.S. Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Canada
        • Canada Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Canada Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Canada Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Canada Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
    • Europe
      • Europe Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
        • Branded
        • Generics
      • Europe Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • Europe Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Europe Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • UK
        • UK Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • UK Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • UK Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • UK Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Germany
        • Germany Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Germany Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Neuraminidase Inhibitors
          • Protease Inhibitors
          • Others
        • Germany Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Germany Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • France
        • France Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • France Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • France Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • France Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Italy
        • Italy Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Italy Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Italy Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Italy Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Spain
        • Spain Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Spain Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Spain Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Spain Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Denmark
        • Denmark Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Denmark Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Denmark Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Denmark Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Sweden
        • Sweden Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Sweden Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Sweden Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Sweden Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Norway
        • Norway Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Norway Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Norway Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Norway Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
    • Asia Pacific
      • Asia Pacific Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
        • Branded
        • Generics
      • Asia Pacific Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • Asia Pacific Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Asia Pacific Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • Japan
        • Japan Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Japan Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Japan Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Japan Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • China
        • China Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • China Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • China Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • China Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • India
        • India Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • India Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • India Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • India Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • South Korea
        • South Korea Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • South Korea Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • South Korea Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • South Korea Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Australia
        • Australia Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Australia Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Australia Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Australia Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Thailand
        • Thailand Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Thailand Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Thailand Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Thailand Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
    • Latin America
      • Latin America Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
        • Branded
        • Generics
      • Latin America Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • Latin America Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Latin America Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • Brazil
        • Brazil Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Brazil Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Brazil Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Brazil Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Mexico
        • Mexico Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Mexico Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Mexico Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Mexico Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Argentina
        • Argentina Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Argentina Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Argentina Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Argentina Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
    • MEA
      • MEA Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
        • Branded
        • Generics
      • MEA Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • MEA Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • MEA Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • South Africa
        • South Africa Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • South Africa Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • South Africa Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • South Africa Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Saudi Arabia
        • Saudi Arabia Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Saudi Arabia Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Saudi Arabia Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Saudi Arabia Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • UAE
        • UAE Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • UAE Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • UAE Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • UAE Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Kuwait
        • Kuwait Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
          • Branded
          • Generics
        • Kuwait Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Kuwait Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
        • Kuwait Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon